The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Delineation of immunotherapeutic predictive versus prognostic transcriptional programs to identify SLC22A5-centric carnitine metabolism-driven resistance to anti-PD-L1 treatment in advanced non–small-cell lung cancer.
 
Yuze Wang
No Relationships to Disclose
 
Ning Gao
No Relationships to Disclose
 
Zhanwen Lin
No Relationships to Disclose
 
Si-Heng Wang
No Relationships to Disclose
 
Jinghong Tan
No Relationships to Disclose
 
Rui Chen
No Relationships to Disclose
 
Zekang Wang
No Relationships to Disclose
 
Zengli Fang
No Relationships to Disclose
 
Weixiong Yang
No Relationships to Disclose
 
Si-Cong Ma
No Relationships to Disclose
 
Chao Cheng
No Relationships to Disclose